Company / Cost of Revenue
Bausch Health Companies Inc. Cost of Revenue History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$2.5B
FY2017
5-year range
-
FY2016-FY2017
Trend
-2.6%
vs FY2016
Sector context
#14 of 85
Health Care
What the data says
Bausch Health Companies Inc.'s cost of revenue of $2.5B is higher than 84% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
$2.5B in FY2017. Top quartile in the Health Care sector.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 85This company $2.5B Sector average $2.0B
▼
+26.4% above sector average
Key checks
Key Insights
- In FY2017, cost of revenue decreased 2.6% year-over-year.
- Ranks #14 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $2.5B | -2.6% |
| FY2016 | $2.6B | +1.6% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026